Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SELDDEC Trial
2025-520725-20-00Phase 2Authorised
- Sponsor
- University Hospital Limerick
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of erythromycin and neomycin in surgical site infection (SSI) (2 arms), sponsored by University Hospital Limerick. Primary endpoint: Incidence of surgical site infection. Planned start Jan 2025; status: authorised.
02
Drugs
erythromycinneomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2025-520725-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520725-20-00.